We are not a conventional
fund manager applying sole
discretion. All investors are also
our general partners in SPVs with
presence in board for decision taking mechanism.
With confidence in our projects ;
🗸 No anual management fees,
🗸 No carried interest stake unless
2x return is generated
🗸 No dry-powder as capital is
raised for only dedicated project
Focusing in lifesciences and
every year we invest in only
upto 10 innovative projects with
the highest potential to generate
≫5x returns in 3 to 5 years.
All patented projects in the
pipeline are fully compliant to
regulations (FDA, EMA, CE, MHRA)
and regulatory proccess is
supported by HF Capital's medical
team to secure promising future.